S.no | Compounds | SwissADME | ||||||
---|---|---|---|---|---|---|---|---|
Lipophilicity | Water Solubility | Pharmacokinetics | Druglikeness | Medicinal Chemistry | ||||
Consensus Log Po/w | Class | GI absorption | Lipinski violations | Veber violations | Muegge violations | Bioavailability Score | ||
1 | 12,28-Oxamanzamine A | 5.3 | Poorly soluble | High | 2 | 0 | 2 | 0.17 |
2 | Parsiguine | 0.74 | Soluble | Low | 2 | 1 | 3 | 0.17 |
3 | Haliclonacyclamine B | 6.58 | Moderately soluble | Low | 1 | 0 | 1 | 0.55 |
4 | Vialinin B | 5.08 | Insoluble | Low | 1 | 1 | 1 | 0.55 |
5 | 6-Deoxymanzamine X | 4.7 | Poorly soluble | High | 1 | 0 | 2 | 0.55 |
6 | Natamycin |  − 0.49 | Soluble | Low | 3 | 1 | 4 | 0.17 |
7 | Olorofim | 3.45 | Poorly soluble | High | 0 | 0 | 0 | 0.55 |
8 | Deoxytopsentin | 3.24 | Poorly soluble | High | 0 | 0 | 0 | 0.55 |
9 | Manzamine E | 4.42 | Poorly soluble | High | 1 | 0 | 1 | 0.55 |
10 | Fascioquinol A | 5.33 | Poorly soluble | Low | 1 | 0 | 1 | 0.56 |
11 | Pramiconazole | 4.06 | Poorly soluble | High | 2 | 0 | 1 | 0.17 |
12 | Fascioquinol D | 5.99 | Poorly soluble | Low | 1 | 0 | 1 | 0.55 |
13 | Saperconazole | 4.28 | Poorly soluble | High | 2 | 1 | 1 | 0.17 |
14 | Nakadomarin A | 4.16 | Moderately soluble | High | 0 | 0 | 0 | 0.55 |
15 | Plakinamine A | 5.99 | Poorly soluble | High | 1 | 0 | 1 | 0.55 |
16 | Fascioquinol C | 6.02 | Poorly soluble | Low | 1 | 0 | 1 | 0.55 |
17 | Hesperidin |  − 0.72 | Soluble | Low | 3 | 1 | 4 | 0.17 |
18 | Epoxyazadiradione | 3.93 | Poorly soluble | High | 0 | 0 | 0 | 0.55 |
19 | Manzamine A | 4.98 | Poorly soluble | High | 2 | 0 | 2 | 0.17 |
20 | Halicyclamine A | 6.13 | Moderately soluble | Low | 1 | 0 | 1 | 0.55 |
21 | Tetrahydrohaliclonacyclamine A | 7.26 | Poorly soluble | Low | 1 | 0 | 1 | 0.55 |
22 | Phaeosphenone | 1.31 | Moderately soluble | Low | 2 | 1 | 2 | 0.17 |
23 | Goniodomin A | 3.29 | Soluble | Low | 2 | 1 | 3 | 0.17 |
24 | Stelletin A | 5.97 | Poorly soluble | High | 1 | 0 | 1 | 0.55 |